May I comment on that one? That's a great one. I would sound a note of caution when we're thinking about all of this and looking at other jurisdictions, because you're entirely correct, but one of the ways they've done that is limited access. Their formularies include fewer of the therapies.
On September 22nd, 2016. See this statement in context.